Vaishali Pharma IPO


Vaishali Pharma IPO

Vaishali Pharma IPO

Vaishali Pharma deals in pharmaceutical formulations, APIs, surgical products, veterinary supplements. It operates both in domestic and export markets. In domestic markets, it largely trades into APIs whereas in export markets, it is into trading and marketing of APIs, formulations, surgical products and others. For export markets, it gets the formulations manufactured by third parties whose facilities are approved and certified by the respective countries for developing the respective products. At present, it has applied for 186 registrations in 13 countries for some of its products, out of which it claims to have successfully received 71 approvals from 7 countries and is in process of obtaining remaining approvals, which will give boost to its export business operations.

It has obtained ISO 9001:2015 Certification for the Quality Management System from Deutsche Accreditation Board, Germany and ISC Global, Dubai, UAE. It is also certified by European Certification Organisation and Compliance Certificate with regards to Council Directive 93/42/EEC as amended 2007/47/EC relating to Surgical Instruments & Medical Devices Directive. The company has received Credit Rating Certification from NSIC CRISIL for the year 2017-18 as well. The company has also been recognized by Government of India as a ―One Star Export House‖ and holds a valid certificate for the same from the Director General of Foreign Trade.

Promoters of Vaishali Pharma – Atul Vasani and Jagruti Vasani

Vaishali Pharma IPO details

Subscription Dates 7 – 10 August 2017
IPO Price band INR71 – 72 per share
Fresh issue 1,976,000 shares (INR14.03 – 14.23 crore)
Offer for sale Nil
Total IPO size 1,976,000 shares (INR14.03 – 14.23 crore)
Minimum bid (lot size) 1,600 shares
Face Value  INR10 per share
Retail Allocation 50%
Listing On NSE Emerge SME platform

Vaishali Pharma’s financial performance (in INR lakh)

FY2013 FY2014 FY2015 FY2016 FY2017
Total revenue 11,909.9 12,156.9 9,882.4 6,989.1 6,711.2
Total expenses 11,821.0 12,095.5 9,867.2 6,989.5 6,609.9
Profit after tax 60.0 30.1 16.2 -3.0 66.4

Vaishali Pharma Limited
706 to 709, 7th Floor, Aravali Business Center, R. C. Patel Road
Off Sodawala Lane, Borivali (West)
Mumbai – 400092

Phone: +91 22 2892 8833
Email: [email protected]


Subscription (no. of times)

Day 1 0.09
Day 2 0.20
Day 3 0.58
Day 4 1.87


Earnings Per Share (EPS): INR2.21

Price/Earnings (P/E) ratio: 32.12 – 32.58

Return on Net Worth (RONW): 17.16%

Net Asset Value (NAV): INR12.90 per share

Bigshare Services Private Limited 
E2, Ansa Industrial Estate, Sakivihar Road,
Sakinaka, Andheri (E),
Mumbai – 400 072

Phone: +91 22 4043 0200 
+91 22 2847 5201
 [email protected]

Vaishali Pharma IPO allotment status is now available on Bigshare Services’ website. Click on this link to get allotment status.

IPO Opening Date: 7 August 2017

IPO Closing Date: 10 August 2017

Finalisation of Basis of Allotment: 16 August 2017

Initiation of refunds: 18 August 2017

Transfer of shares to demat accounts: 21 August 2017

Listing Date: 22 August 2017

Listing Price on NSE SME: INR71.9 per share (down 0.1% from IPO price)

Closing Price on NSE SME: INR70.35 per share (down 2.3% from IPO price)


  1. Pls help
    I’m new 2 market & want 2 start with an IPO.
    I hold an bank account with Indian bank which don’t support IPO online…. So can I use my father SBI net banking and fill IPO details of my demat & Pan no in IPO section of my father SBI online for the IPO. Will it be accepted?? Or I have 2 apply only by bank account in My name only for IPO online

    • SBI allows adding more than one applications so you can use your father’s net banking to apply in IPOs. All you need are your PAN and DP details.


Please enter your comment!
Please enter your name here